Company Statements
Daiichi Sankyo Europe's Statement Regarding Esperion Therapeutics' Complaint
View Resource
Industry Veteran, Dr. Mark Rutstein, Joins Daiichi Sankyo to Lead Global Oncology Clinical Development Program
View Resource
Daiichi Sankyo, Inc. has taken measures to contribute to the overall effort to limit the spread of the virus that causes COVID-19.
View Resource